000710 贝瑞基因
交易中 07-24 13:25:36
资讯
新帖
简况
贝瑞基因(000710)7月23日主力资金净卖出54.31万元
证券之星 · 07-23 15:27
贝瑞基因(000710)7月23日主力资金净卖出54.31万元
贝瑞基因(000710)7月22日主力资金净卖出2297.89万元
证券之星 · 07-22 15:22
贝瑞基因(000710)7月22日主力资金净卖出2297.89万元
贝瑞基因:截至2024年7月10日公司股东人数46,235户
证券之星 · 07-19
贝瑞基因:截至2024年7月10日公司股东人数46,235户
贝瑞基因最新公告:预计上半年净利800万元-1200万元 同比扭亏
证券之星 · 07-12
贝瑞基因最新公告:预计上半年净利800万元-1200万元 同比扭亏
贝瑞基因(000710.SZ)发预盈 半年度净利润800万元-1200万元 同比扭亏为盈
智通财经网 · 07-12
贝瑞基因(000710.SZ)发预盈 半年度净利润800万元-1200万元 同比扭亏为盈
贝瑞基因(000710.SZ)控股股东拟被动减持不超1%股份
智通财经网 · 07-09
贝瑞基因(000710.SZ)控股股东拟被动减持不超1%股份
贝瑞基因最新公告:因股票质押违约 控股股东高扬拟被动减持不超1%股份
证券之星 · 07-09
贝瑞基因最新公告:因股票质押违约 控股股东高扬拟被动减持不超1%股份
贝瑞基因:截至2024年6月7日公司股东人数48,088户
证券之星 · 06-21
贝瑞基因:截至2024年6月7日公司股东人数48,088户
贝瑞基因最新公告:控股股东之一致行动人所持公司部分股份将被司法拍卖
证券之星 · 06-17
贝瑞基因最新公告:控股股东之一致行动人所持公司部分股份将被司法拍卖
贝瑞基因:截至2024年5月31日公司股东人数49,379户
证券之星 · 06-07
贝瑞基因:截至2024年5月31日公司股东人数49,379户
贝瑞基因:公司境外收入主要来自医学检测服务
证券之星 · 05-24
贝瑞基因:公司境外收入主要来自医学检测服务
贝瑞基因(000710)5月9日主力资金净卖出2073.32万元
证券之星 · 05-09
贝瑞基因(000710)5月9日主力资金净卖出2073.32万元
贝瑞基因(000710)5月8日主力资金净买入4020.99万元
证券之星 · 05-08
贝瑞基因(000710)5月8日主力资金净买入4020.99万元
异动快报:贝瑞基因(000710)5月8日9点31分触及涨停板
证券之星 · 05-08
异动快报:贝瑞基因(000710)5月8日9点31分触及涨停板
贝瑞基因:公司高管薪酬详见《关于对深圳证券交易所2021年年报问询函的回复公告》及历年年度报告
证券之星 · 04-30
贝瑞基因:公司高管薪酬详见《关于对深圳证券交易所2021年年报问询函的回复公告》及历年年度报告
4月25日贝瑞基因涨停分析:辅助生殖,精准医疗,基因测序概念热股
证券之星 · 04-25
4月25日贝瑞基因涨停分析:辅助生殖,精准医疗,基因测序概念热股
贝瑞基因(000710)4月25日主力资金净买入2801.71万元
证券之星 · 04-25
贝瑞基因(000710)4月25日主力资金净买入2801.71万元
异动快报:贝瑞基因(000710)4月25日9点34分触及涨停板
证券之星 · 04-25
异动快报:贝瑞基因(000710)4月25日9点34分触及涨停板
图解贝瑞基因一季报:第一季度单季净利润同比增139.71%
证券之星 · 04-25
图解贝瑞基因一季报:第一季度单季净利润同比增139.71%
贝瑞基因最新公告:一季度净利润823.51万元 同比扭亏
证券之星 · 04-24
贝瑞基因最新公告:一季度净利润823.51万元 同比扭亏
加载更多
公司概况
公司名称:
成都市贝瑞和康基因技术股份有限公司
所属行业:
专业技术服务业
上市日期:
1997-04-22
主营业务:
成都市贝瑞和康基因技术股份有限公司主营业务为以高通量测序技术为基础的基因检测服务和基因检测相关的设备、试剂销售。公司主要产品为基础科研服务、医学检测服务、试剂及仪器。公司是少数通过“产品+服务”的综合方案为各级医院、第三方医学实验室等医疗机构提供医学产品及服务的公司之一,凭借NIPT项目的先发优势,不断多元化基因检测服务项目并适时进行产品化,凭借在临床应用需求的洞察力和在临床进行商业推广的成功经验,确立了公司在遗传学领域的领导地位。公司自主研发的、具有万级技术分辨率的cSMART液态活检技术已获得国内外专利,凭借该技术优势,确立了公司在肿瘤学领域的领先地位。
发行价格:
5.10
{"stockData":{"symbol":"000710","market":"SZ","secType":"STK","nameCN":"贝瑞基因","latestPrice":7,"timestamp":1721798736000,"preClose":7.12,"halted":0,"volume":4950200,"delay":0,"floatShares":300000000,"shares":354000000,"eps":-1.1265,"marketStatus":"交易中","marketStatusCode":2,"change":-0.12,"latestTime":"07-24 13:25:36","open":7.04,"high":7.14,"low":6.91,"amount":34603400,"amplitude":0.0323,"askPrice":7.01,"askSize":160,"bidPrice":7,"bidSize":306,"shortable":0,"etf":0,"ttmEps":-1.1265,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721804400000},"adr":0,"adjPreClose":7.12,"symbolType":"stock","openAndCloseTimeList":[[1721784600000,1721791800000],[1721797200000,1721804400000]],"highLimit":7.83,"lowLimit":6.41,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":353521465,"pbRate":1.34,"roa":"--","roe":"0.44%","epsLYR":-1.21,"committee":0.275076,"marketValue":2475000000,"floatMarketCap":2100000000,"peRate":-6.213937,"changeRate":-0.0169,"turnoverRate":0.0165,"status":1},"requestUrl":"/m/hq/s/000710","defaultTab":"news","newsList":[{"id":"2453709469","title":"贝瑞基因(000710)7月23日主力资金净卖出54.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453709469","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453709469?lang=zh_cn&edition=full","pubTime":"2024-07-23 15:27","pubTimestamp":1721719677,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月23日收盘,贝瑞基因报收于7.12元,上涨0.28%,换手率3.39%,成交量10.16万手,成交额7279.69万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:贝瑞基因2024年一季报显示,公司主营收入2.79亿元,同比下降0.26%;归母净利润823.51万元,同比上升139.71%;扣非净利润998.99万元,同比上升148.79%;负债率29.46%,投资收益-280.36万元,财务费用231.17万元,毛利率55.05%。贝瑞基因主营业务:以高通量测序技术为基础的基因检测和设备、试剂销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300023641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0081","BK0139","BK0028","BK0221","000710","BK0086","BK0042","BK0102"],"gpt_icon":0},{"id":"2453737953","title":"贝瑞基因(000710)7月22日主力资金净卖出2297.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453737953","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453737953?lang=zh_cn&edition=full","pubTime":"2024-07-22 15:22","pubTimestamp":1721632967,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月22日收盘,贝瑞基因报收于7.1元,下跌3.66%,换手率4.37%,成交量13.12万手,成交额9258.87万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:贝瑞基因2024年一季报显示,公司主营收入2.79亿元,同比下降0.26%;归母净利润823.51万元,同比上升139.71%;扣非净利润998.99万元,同比上升148.79%;负债率29.46%,投资收益-280.36万元,财务费用231.17万元,毛利率55.05%。贝瑞基因主营业务:以高通量测序技术为基础的基因检测和设备、试剂销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200013635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","BK0042","BK0102","000710","BK0221","BK0081","BK0139"],"gpt_icon":0},{"id":"2452239054","title":"贝瑞基因:截至2024年7月10日公司股东人数46,235户","url":"https://stock-news.laohu8.com/highlight/detail?id=2452239054","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452239054?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:02","pubTimestamp":1721383368,"startTime":"0","endTime":"0","summary":"贝瑞基因董秘:投资者您好,控股股东及其一致行动人股份变动系其股票质押违约被动减持,详见公司于2024年7月10日、2024年7月17日在巨潮资讯网披露的《关于控股股东被动减持股份的预披露公告 》和《关于控股股东之一致行动人所持公司部分股份被司法拍卖的进展公告》,感谢您的关注。谢谢贝瑞基因董秘:投资者您好,截至2024年7月10日公司股东人数46,235户,感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900040339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0081","BK0139","BK0028","BK0221","000710","BK0086","BK0042","BK0102"],"gpt_icon":0},{"id":"2450307960","title":"贝瑞基因最新公告:预计上半年净利800万元-1200万元 同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2450307960","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450307960?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:10","pubTimestamp":1720779029,"startTime":"0","endTime":"0","summary":"贝瑞基因公告,预计上半年净利800万元-1200万元,同比扭亏。报告期内,公司持续提升运营质量,合理控制成本,毛利率水平较去年同期提升。公司强化费用管控,期间费用较去年同期下降。公司持有的Prenetics股份按照公允价值计量确认的变动损失较去年同期下降。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200040022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000710","BK0102","BK0081","BK0139","BK0042","BK0086","BK0221"],"gpt_icon":0},{"id":"2450302580","title":"贝瑞基因(000710.SZ)发预盈 半年度净利润800万元-1200万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2450302580","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450302580?lang=zh_cn&edition=full","pubTime":"2024-07-12 17:58","pubTimestamp":1720778322,"startTime":"0","endTime":"0","summary":"智通财经APP讯,贝瑞基因(000710.SZ)披露2024年半年度业绩预告,该公司预计报告期归属于上市公司股东的净利润800万元-1200万元,扣除非经常性损益后的净利润750万元-1150万元,同比扭亏为盈。报告期内,该公司持续提升运营质量,合理控制成本,毛利率水平较去年同期提升。公司强化费用管控,期间费用较去年同期下降。此外,公司持有的Prenetics股份按照公允价值计量确认的变动损失较去年同期下降。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["000710"],"gpt_icon":0},{"id":"2450040830","title":"贝瑞基因(000710.SZ)控股股东拟被动减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2450040830","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450040830?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:28","pubTimestamp":1720531717,"startTime":"0","endTime":"0","summary":"贝瑞基因(000710.SZ)发布公告,公司控股股东高扬先生因股票质押违约将被质权...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0086","BK0081","BK0139","BK0221","BK0028","BK0102","000710","BK0042"],"gpt_icon":0},{"id":"2450045733","title":"贝瑞基因最新公告:因股票质押违约 控股股东高扬拟被动减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2450045733","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450045733?lang=zh_cn&edition=full","pubTime":"2024-07-09 19:50","pubTimestamp":1720525811,"startTime":"0","endTime":"0","summary":"贝瑞基因公告,公司控股股东高扬因股票质押违约,将被质权人国信证券通过集中竞价方式减持股份不超过353.52万股,减持比例不超过公司股份总数的1%,减持期间为自本减持计划公告之日起十五个交易日后的三个月内。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900043741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","BK0102","BK0028","BK0139","000710","BK0081","BK0086","BK0042"],"gpt_icon":0},{"id":"2445185736","title":"贝瑞基因:截至2024年6月7日公司股东人数48,088户","url":"https://stock-news.laohu8.com/highlight/detail?id=2445185736","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445185736?lang=zh_cn&edition=full","pubTime":"2024-06-21 17:03","pubTimestamp":1718960612,"startTime":"0","endTime":"0","summary":"证券之星消息,贝瑞基因(000710)06月21日在投资者关系平台上答复投资者关心的问题。投资者:董秘您好!请问截止6月10号,公司的股东人数是多少?谢谢贝瑞基因董秘:投资者您好,截至2024年6月7日公司股东人数48,088户,感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100036421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0028","BK0042","BK0139","BK0221","BK0081","000710","BK0102"],"gpt_icon":0},{"id":"2444031150","title":"贝瑞基因最新公告:控股股东之一致行动人所持公司部分股份将被司法拍卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2444031150","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444031150?lang=zh_cn&edition=full","pubTime":"2024-06-17 18:51","pubTimestamp":1718621468,"startTime":"0","endTime":"0","summary":"贝瑞基因公告,公司于近日收到控股股东之一致行动人侯颖女士发送的《成渝金融法院网络司法拍卖事项通知书》并通过司法拍卖网络平台查询获悉,侯颖女士持有的公司部分股份将由成渝金融法院于2024年7月15日10:00时起至2024年7月16日10:00时止在淘宝网司法拍卖网络平台上进行公开拍卖活动,拍卖标的为侯颖女士持有的公司528.4925万股股票,占其持有公司股份的比例为26.16%,占公司总股本的比例为1.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061700022891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","BK0102","BK0028","BK0139","000710","BK0081","BK0086","BK0042"],"gpt_icon":0},{"id":"2441051350","title":"贝瑞基因:截至2024年5月31日公司股东人数49,379户","url":"https://stock-news.laohu8.com/highlight/detail?id=2441051350","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441051350?lang=zh_cn&edition=full","pubTime":"2024-06-07 19:02","pubTimestamp":1717758139,"startTime":"0","endTime":"0","summary":"证券之星消息,贝瑞基因(000710)06月07日在投资者关系平台上答复投资者关心的问题。投资者:请问截止5月31日盘后公司登记在册的股东人数是多少?谢谢贝瑞基因董秘:投资者您好,截至2024年5月31日公司股东人数49,379户,感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700040266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0221","000710","BK0139","BK0102","BK0081","BK0028"],"gpt_icon":0},{"id":"2437081979","title":"贝瑞基因:公司境外收入主要来自医学检测服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2437081979","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437081979?lang=zh_cn&edition=full","pubTime":"2024-05-24 18:02","pubTimestamp":1716544962,"startTime":"0","endTime":"0","summary":"谢谢贝瑞基因董秘:投资者您好,在肿瘤领域,福建和瑞基因科技有限公司作为公司参股公司,是全球肿瘤基因检测行业及癌症早筛赛道的代表性企业,本公司未直接开展癌症早筛业务,感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400036577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0221","BK0028","BK0102","BK0081","000710","BK0042","BK0086"],"gpt_icon":0},{"id":"2434054235","title":"贝瑞基因(000710)5月9日主力资金净卖出2073.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434054235","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434054235?lang=zh_cn&edition=full","pubTime":"2024-05-09 15:23","pubTimestamp":1715239419,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月9日收盘,贝瑞基因报收于9.27元,下跌4.33%,换手率11.48%,成交量34.43万手,成交额3.22亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:贝瑞基因2024年一季报显示,公司主营收入2.79亿元,同比下降0.26%;归母净利润823.51万元,同比上升139.71%;扣非净利润998.99万元,同比上升148.79%;负债率29.46%,投资收益-280.36万元,财务费用231.17万元,毛利率55.05%。贝瑞基因主营业务:以高通量测序技术为基础的基因检测和设备、试剂销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900022042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0102","BK0139","BK0221","BK0042","BK0028","BK0081","BK0086"],"gpt_icon":0},{"id":"2433654713","title":"贝瑞基因(000710)5月8日主力资金净买入4020.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433654713","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433654713?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:19","pubTimestamp":1715152797,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月8日收盘,贝瑞基因报收于9.69元,上涨4.98%,换手率14.9%,成交量44.7万手,成交额4.39亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:贝瑞基因2024年一季报显示,公司主营收入2.79亿元,同比下降0.26%;归母净利润823.51万元,同比上升139.71%;扣非净利润998.99万元,同比上升148.79%;负债率29.46%,投资收益-280.36万元,财务费用231.17万元,毛利率55.05%。贝瑞基因主营业务:以高通量测序技术为基础的基因检测和设备、试剂销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800021211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0081","BK0042","BK0221","BK0102","BK0139","BK0028","BK0086","000710"],"gpt_icon":0},{"id":"2433766962","title":"异动快报:贝瑞基因(000710)5月8日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2433766962","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433766962?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:35","pubTimestamp":1715132141,"startTime":"0","endTime":"0","summary":"证券之星5月8日盘中消息,9点31分贝瑞基因触及涨停板。目前价格10.15,上涨9.97%。其所属行业医疗服务目前上涨。领涨股为ST中珠。该股为体外诊断,基因测序,精准医疗概念热股,当日体外诊断概念上涨2.36%,基因测序概念上涨2.17%,精准医疗概念上涨1.95%。5月7日的资金流向数据方面,主力资金净流入572.87万元,占总成交额2.74%,游资资金净流出1595.4万元,占总成交额7.62%,散户资金净流入1022.53万元,占总成交额4.88%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800014853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0221","BK0028","BK0086","BK0042","000710","BK0081","BK0139"],"gpt_icon":0},{"id":"2431424643","title":"贝瑞基因:公司高管薪酬详见《关于对深圳证券交易所2021年年报问询函的回复公告》及历年年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2431424643","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431424643?lang=zh_cn&edition=full","pubTime":"2024-04-30 20:50","pubTimestamp":1714481435,"startTime":"0","endTime":"0","summary":"贝瑞基因董秘:投资者您好,公司高管薪酬详见《关于对深圳证券交易所2021年年报问询函的回复公告》及历年年度报告,感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000049902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0102","BK0139","BK0042","BK0221","000710","BK0081","399001","BK0086"],"gpt_icon":0},{"id":"2430421501","title":"4月25日贝瑞基因涨停分析:辅助生殖,精准医疗,基因测序概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430421501","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430421501?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:28","pubTimestamp":1714030109,"startTime":"0","endTime":"0","summary":"证券之星消息,贝瑞基因涨停收盘,收盘价8.1元。该股于9点34分涨停,未打开涨停,截止收盘封单资金为7955.5万元,占其流通市值3.27%。4月25日的资金流向数据方面,主力资金净流入2801.71万元,占总成交额35.16%,游资资金净流出1209.99万元,占总成交额15.18%,散户资金净流出1591.73万元,占总成交额19.97%。近5日资金流向一览见下表:该股为辅助生殖,精准医疗,基因测序概念热股,当日辅助生殖概念上涨1.63%,精准医疗概念上涨1.33%,基因测序概念上涨1.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500026151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0221","BK0042","BK0086","BK0139","BK0081","BK0028","BK0102"],"gpt_icon":0},{"id":"2430588429","title":"贝瑞基因(000710)4月25日主力资金净买入2801.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430588429","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430588429?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:19","pubTimestamp":1714029547,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月25日收盘,贝瑞基因报收于8.1元,上涨10.05%,涨停,换手率3.35%,成交量10.04万手,成交额7968.71万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:贝瑞基因2024年一季报显示,公司主营收入2.79亿元,同比下降0.26%;归母净利润823.51万元,同比上升139.71%;扣非净利润998.99万元,同比上升148.79%;负债率29.46%,投资收益-280.36万元,财务费用231.17万元,毛利率55.05%。贝瑞基因主营业务:以高通量测序技术为基础的基因检测和设备、试剂销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500025749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","BK0102","BK0028","BK0139","000710","BK0081","BK0086","BK0042"],"gpt_icon":0},{"id":"2430541415","title":"异动快报:贝瑞基因(000710)4月25日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2430541415","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430541415?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:36","pubTimestamp":1714008978,"startTime":"0","endTime":"0","summary":"证券之星4月25日盘中消息,9点34分贝瑞基因触及涨停板。目前价格8.1,上涨10.05%。其所属行业医疗服务目前下跌。领涨股为ST中珠。该股为体外诊断,医疗器械,精准医疗概念热股,当日体外诊断概念上涨0.6%,医疗器械概念上涨0.31%。4月24日的资金流向数据方面,主力资金净流出47.12万元,占总成交额0.69%,游资资金净流出75.54万元,占总成交额1.11%,散户资金净流入122.66万元,占总成交额1.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500019083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","BK0042","BK0081","BK0139","BK0028","000710","BK0102","BK0086"],"gpt_icon":0},{"id":"2430909461","title":"图解贝瑞基因一季报:第一季度单季净利润同比增139.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430909461","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430909461?lang=zh_cn&edition=full","pubTime":"2024-04-25 01:41","pubTimestamp":1713980486,"startTime":"0","endTime":"0","summary":"证券之星消息,贝瑞基因2024年一季报显示,公司主营收入2.79亿元,同比下降0.26%;归母净利润823.51万元,同比上升139.71%;扣非净利润998.99万元,同比上升148.79%;负债率29.46%,投资收益-280.36万元,财务费用231.17万元,毛利率55.05%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500002378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2429512374","title":"贝瑞基因最新公告:一季度净利润823.51万元 同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2429512374","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429512374?lang=zh_cn&edition=full","pubTime":"2024-04-24 22:00","pubTimestamp":1713967235,"startTime":"0","endTime":"0","summary":"贝瑞基因披露2024年一季度报告,报告期营业收入2.79亿元,同比下降0.26%;归属于上市公司股东的净利润823.51万元,同比扭亏为盈;基本每股收益0.02元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400046398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-04-22","address":"四川省成都市龙泉驿区经济技术开发区(龙泉驿区)成都汽车城大道333号","stockEarnings":[{"period":"1week","weight":-0.0391},{"period":"1month","weight":-0.026},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.2929},{"period":"1year","weight":-0.327},{"period":"ytd","weight":-0.3819}],"companyName":"成都市贝瑞和康基因技术股份有限公司","boardCode":"AI0074","perCapita":"6489股","boardName":"专业技术服务业","registeredCapital":"35352万元","compareEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.0276},{"period":"3month","weight":-0.0425},{"period":"6month","weight":0.0032},{"period":"1year","weight":-0.0786},{"period":"ytd","weight":-0.02}],"survey":" 成都市贝瑞和康基因技术股份有限公司主营业务为以高通量测序技术为基础的基因检测服务和基因检测相关的设备、试剂销售。公司主要产品为基础科研服务、医学检测服务、试剂及仪器。公司是少数通过“产品+服务”的综合方案为各级医院、第三方医学实验室等医疗机构提供医学产品及服务的公司之一,凭借NIPT项目的先发优势,不断多元化基因检测服务项目并适时进行产品化,凭借在临床应用需求的洞察力和在临床进行商业推广的成功经验,确立了公司在遗传学领域的领导地位。公司自主研发的、具有万级技术分辨率的cSMART液态活检技术已获得国内外专利,凭借该技术优势,确立了公司在肿瘤学领域的领先地位。","serverTime":1721798737482,"listedPrice":5.1,"stockholders":"46235人(较上一季度减少3.85%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"贝瑞基因,000710,贝瑞基因股票,贝瑞基因股票老虎,贝瑞基因股票老虎国际,贝瑞基因行情,贝瑞基因股票行情,贝瑞基因股价,贝瑞基因股市,贝瑞基因股票价格,贝瑞基因股票交易,贝瑞基因股票购买,贝瑞基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}